Pacira | PCRX - Market Capitalization


Pacira reported $1.2B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Astellas Pharma JPY 4.56T 770.92B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Cara Therapeutics USD 366M 338M Sep/2025
Coherus Biosciences USD 172M 19M Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
J&J USD 595.26B 16.1B Jul/2026
Ligand Pharmaceuticals USD 3.98B 241M Mar/2026
Nektar Therapeutics USD 12.82B 11.96B Jul/2026
Novo Nordisk A/S DKK 1.03T 421.31B Mar/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.31B 604M Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Supernus Pharmaceuticals USD 2.98B 126M Mar/2026
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
Xeris Pharmaceuticals USD 1.11B 112M Jul/2026
Zoetis USD 49.71B 5.74B Mar/2026